Genmab A/S
GMAB
$24.65
$0.230.94%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 336.00M | 195.00M | 549.50M | 186.55M | 203.00M |
| Total Depreciation and Amortization | 16.00M | 16.00M | 16.44M | 16.50M | 14.00M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -185.00M | 1.00M | -186.36M | 173.73M | 102.00M |
| Change in Net Operating Assets | -105.00M | 75.00M | 8.00M | -77.22M | -100.00M |
| Cash from Operations | 62.00M | 287.00M | 387.58M | 299.58M | 219.00M |
| Capital Expenditure | -10.00M | -12.00M | -13.43M | -5.60M | -4.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | -1.78B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 36.00M | -31.00M | 25.15M | 38.61M | 517.00M |
| Cash from Investing | 26.00M | -43.00M | 11.72M | 33.01M | -1.27B |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -4.00M | -2.00M | 0.00 | -17.00M | -3.00M |
| Issuance of Common Stock | 6.00M | 1.00M | 11.00M | 43.00M | 2.00M |
| Repurchase of Common Stock | -408.00M | -12.00M | -8.00M | -302.00M | -439.00M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -406.00M | -13.00M | 428.70K | -40.67M | -440.00M |
| Foreign Exchange rate Adjustments | -5.00M | 8.00M | 102.76M | 4.42M | -14.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -323.00M | 239.00M | 502.49M | 296.34M | -1.51B |